HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 132 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,581,000 | -10.4% | 197,557 | +1.6% | 0.00% | -20.0% |
| Q4 2020 | $6,226,000 | +31.3% | 194,457 | +32.5% | 0.01% | 0.0% |
| Q3 2020 | $4,742,000 | +17.3% | 146,811 | +0.2% | 0.01% | 0.0% |
| Q2 2020 | $4,043,000 | +61.2% | 146,540 | +4.3% | 0.01% | +25.0% |
| Q1 2020 | $2,508,000 | -39.6% | 140,540 | -15.1% | 0.00% | -20.0% |
| Q4 2019 | $4,149,000 | +36.3% | 165,500 | -3.0% | 0.01% | 0.0% |
| Q3 2019 | $3,045,000 | +43.8% | 170,700 | +77.4% | 0.01% | +150.0% |
| Q2 2019 | $2,117,000 | -31.8% | 96,200 | -5.2% | 0.00% | -50.0% |
| Q1 2019 | $3,104,000 | -6.8% | 101,500 | -29.7% | 0.00% | +33.3% |
| Q4 2018 | $3,332,000 | +97.2% | 144,299 | +174.9% | 0.00% | +50.0% |
| Q3 2018 | $1,690,000 | +2.7% | 52,499 | -3.8% | 0.00% | 0.0% |
| Q2 2018 | $1,645,000 | +1.9% | 54,599 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $1,614,000 | -21.2% | 54,599 | +5.0% | 0.00% | 0.0% |
| Q4 2017 | $2,049,000 | – | 51,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |